Drug
Las41005
Las41005: highest development phase Phase 3, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAS41005 NCT00987246 | Phase 3 | Actinic Keratosis |
Latest
No recent events.
Follow Las41005 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.